Revolax Sub-Q Lidocaine

Revolax Sub-Q Lidocaine is the thickest and most viscous dermal filler in the REVOLAX range, manufactured by Across Co., Ltd in South Korea and developed for deep structural correction, facial contouring and augmentation. Clinics use it for the cheeks, cheekbones, chin, nose and jawline, as well as for severely deep lines and deep nasolabial folds. It contains cross-linked hyaluronic acid at 24 mg/mL and 0.3% (3 mg/mL) lidocaine, is injected into the deep subcutaneous plane with a 25G needle and is intended strictly for professional use.

• The thickest gel in the REVOLAX range, for deep structural correction and moulding
• Corrects severely deep lines and supports face contouring and augmentation
• Best suited to the cheek, chin, nose and jawline
• Monophasic cross-linked hyaluronic acid at 24 mg/mL, cross-linked with BDDE, with a BDDE residue of less than 2 ppm
• Contains lidocaine hydrochloride 3 mg/mL, 0.3%, giving an analgesic effect during treatment
• Supplied as a 1.1 ml syringe with two ultra thin wall 25G needles
• Duration of 8 to 12 months, with a 24 month shelf life
• Supported by a randomised, evaluator-blind, split-face clinical study in nasolabial folds

適応と専門的な使用

主な適応

• Intradermal implantation for volume loss and facial morphological asymmetry
• Severely deep lines
• Face contouring and augmentation
• Cheek and cheekbone augmentation
• Chin augmentation
• Nose reshaping
• Jawline contouring

専門的な使用

Revolax Sub-Q with Lidocaine is an injectable medical device for administration by trained medical professionals only, and is not for retail sale or self-administration. It is placed in the deep subcutaneous plane for structural correction, volume enhancement and contouring, which demands advanced anatomical knowledge. Before treatment the patient's suitability and medical history must be assessed, and the patient informed of the indications, contraindications and possible adverse effects. The area to be treated should be disinfected thoroughly and the product injected under sterile conditions; keep the syringe at room temperature for 30 minutes before injection and press the plunger until a small drop is visible at the needle tip. It must not be injected into blood vessels, and it must not be injected into the eye contour, meaning the ocular circle or the eyelids. If the needle blocks, do not increase pressure on the plunger rod; stop and replace the needle.

施術部位

• Cheeks and cheekbones
• Chin
• Nose
• Jawline
• Nasolabial folds

対象となる患者

For adult patients assessed as suitable by the treating practitioner, typically those seeking deep structural correction, facial contouring or augmentation of the cheeks, cheekbones, chin, nose or jawline. It must not be used in women who are pregnant or breastfeeding, in people under 18 years of age, in patients known to be hypersensitive to hyaluronic acid, or in patients who tend to develop hypertrophic scarring. It must not be used in association with laser therapy, chemical peeling or dermabrasion, or in areas presenting cutaneous inflammatory or infectious processes. It must not be used in patients with coagulation disorders, or who have received thrombolytic, anticoagulant or platelet aggregation inhibitor therapy in the previous two weeks. Because it contains lidocaine, the total dose administered must be taken into account where a dental block or topical lidocaine is used at the same time; high doses above 400 mg can cause acute toxic reactions affecting the central nervous system and cardiac conduction. Lidocaine should be used with caution in patients receiving other local anaesthetics or structurally related agents such as certain antiarrhythmics, and in patients with epilepsy, cardiac conduction disorders, severe hepatic impairment or severe renal dysfunction.

作用の仕組み： Revolax Sub-Q Lidocaine ​

Allparaで注文する理由

Allparaは、正規品で検証済みの REVOLAX 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問